Biventricular Pacing

2

Review clinical trials related to Biventricular Pacing. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy

The present study is a prospective, multicenter, non-inferiority, randomized controlled trail. It aims to investigate whether the efficacy of conduction system pacing (CSP) is non-inferior to biventricular pacing (BiVP) in patients with heart failure and right ventricular pacing (RVP) requiring upgrading to cardiac resynchronization therapy (CRT).

Participants needed: 66
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital with Nanjing Medical UniversityUpdated: May 14, 2026Locations: 1
Eligibility criteria

Patients with symptomatic heart failure (LVEF <50%) after right ventricular paci... [+5]

History of acute myocardial infarction within 3 months before enrollment; [+9]

Status: Recruiting

UHF ECG in LBBB and Response to CRT Prediction

The main objective of the project is to demonstrate that in patients with heart failure and QRS complex of nonRBBB morphology lasting over 130 ms, UHF-ECG can differentiate patients with trueLBBB from IVCD better than existing approaches based on the assessment of QRS complex morphology and duration from 12-lead ECG. Another goal of the proposed study is to demonstrate that trueLBBB patients will benefit more from CRT using left bundle branch pacing than from CRT using biventricular pacing. The final aim of the project is to demonstrate that the echocardiographic and clinical response in patients with intraventricular conduction disturbance will be dependent on the degree of reduction in ventricular dyssynchrony after CRT.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Faculty Hospital Kralovske VinohradyUpdated: Jul 14, 2025Locations: 1
Eligibility criteria

HF due to ischemic or non-ischemic cardiomyopathy [+5]

Age ˂18 years [+11]